Capital Markets Corporate Life Sciences

Sue Charles


Sue leads our global Life Sciences practice. She co-founded and was CEO of Northbank Communications, a highly-regarded Life Sciences consultancy, acquired by Instinctif Partners in October 2007. A serial entrepreneur, she was also co-founder of De Facto which she led for 10 years. Recognized for her prestigious PR campaign to announce Dolly the Cloned Sheep, prior experience also includes consulting to life science venture capitalists and interim biotech CEOs. With a Masters in Biochemistry and an MBA, she has more than 30 years’ communications experience, across financial, corporate, science and marketing communications, and is regarded as an industry leader in Life Sciences communications.

Sue was elected to the Board of the BioIndustry Association (BIA) in 2017 and was named as one of the most inspirational women in UK Life Sciences in the ’50 Movers & Shakers in BioBusiness’ in 2016 and again in 2017.